Drug recall · October 5, 2022
ClomiPRAMINE Hydrochloride Capsules recall
Why: Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
- Lots / codes
Lot#: B14221, Exp. Date 02/2023
- Quantity
- 960 bottles (100 capsules)
- Company
- Leading Pharma, LLC, Fairfield, NJ
- Distribution
- Nationwide within the United States
- Initiated
- August 23, 2022 · Voluntary: Firm initiated
- Classified
- September 28, 2022
- Reported
- October 5, 2022
- Ended
- September 28, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clomipramine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.